VRTX: Just to add 2 more things from the call. Trial would be naive and would have two other arms Telaprevir+SOC and 222+SOC. I couldn't quite understand the speaker in the 36-37 minute mark if I heard correctly I think he said something about ramping up to 12 weeks of treatment.
Market Data 
Markets 
AI
